REFERENCES
- Brydak LB and Calbecka M: Immunogenicity of influenza vaccine in patients with hemato-oncological disorders. Leuk Lymphoma 32, 369–374, 1999.
- Nordøy T, Aaberge IS, Husebekk A, Samdal HH, Steinert S, et al.: Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae. Med Oncol 19 71–78, 2002.
- Robertson JD, Nagesh K, Jowitt SN, Dougal M, Anderson H, et al.: Immunogenicity of vaccinationagainstinfluenza, Streptococcuspneumoniae and Haemophilusinfluenzae type B in patients with multiplemyeloma. Br J Cancer 82, 1261–1265, 2000.
- Hartkamp A, Mulder AH, Rijkers GT, van Velzen-Blad H, and Biesma DH: Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia. Vaccine 19, 1671–1677, 2001.
- Jo YM, Song JY, Hwang IS, Lee J, Oh SC, et al.: Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. J Med Virol 81, 722–727, 2009.
- Fraker PJ, Jardieu P, and Cook J: Zinc deficiency and the immune function. Arch Dermatol Res 123, 1699–1701, 1987.
- Strand TA, Aaberge IS, Maage A, Ulvestad E, and Sommerfelt H. The immune response to pneumococcal polysaccharide vaccine in zinc-depleted mice. Scand J Immunol 58, 76–80, 2003.
- Strand TA, Hollingshead SK, Julshamn K, Briles DE, Blomberg B, et al.: Effects of zinc deficiency and pneumococcal surface protein an immunization on zinc status and the risk of severe infection in mice. Infect Immun 71, 2009–2013, 2003.
- Strand TA, Briles DE, Gjessing HK, Maage A, Bhan MK, Sommerfelt H.: Pneumococcal pulmonary infection, septicaemia and survival in young zinc-depleted mice. Br J Nutr 86, 301–306, 2001.
- Osendarp SJ, Prabhakar H, Fuchs GJ, van Raaij JM, Mahmud H, Tofail F, et al.: Immunization with the heptavalent pneumococcal conjugate vaccine in Bangladeshi infants and effects of zinc supplementation. Vaccine 25, 3347–3354, 2007.
- Deloria-Knoll M, Steinhoff M, Semba RD, Nelson K, Vlahov D, et al.: Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial. Vaccine 24, 1670–1679, 2006.
- Hamza SA, Mousa SM, Taha SE, Adel LA, Samaha HE, et al.: Immune response of 23-valent pneumococcal polysaccharide vaccinated elderly and its relation to frailty indices, nutritional status, and serum zinc levels. Geriatr Gerontol Int 12, 223–229, 2012.
- Rothery E: Analytical Methods for Graphite Tube Atomizers. Mulgrave Vitoria, Australia: Varian Australia Pty Lty, 1988.
- Inostroza J, Villanueva S, Mason K, Leiva LE, and Sorensen RU: Effects of absorption with pneumococcal type 22F polysaccharide on maternal, cord blood, and infant immunoglobulin G antipneumococcal polysaccharide antibodies. Clin Diagn Lab Immunol 12, 722–726, 2005.
- Sorensen RU, Hidalgo H, Moore C, and Leiva L: Postimmunization pneumococcal antibody titers and IgG subclasses. Pediatr Pulmonol 22, 167–173, 1996.
- Costa BTC, Nagao AT, Arslanian C, Carneiro Sampaio MM, Naspitz CK, et al.: Immunological evaluation of allergic respiratory children with recurrent sinusitis. Pediatr Allergy Immunol 16, 534–538, 2005.
- Feikin DR, Elie CM, Goetz MB, Lennox JL, Carlone GM, et al.: Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults. Clin Diagn Lab Immunol 11, 137–141, 2004.
- Go ES and Ballas ZK: Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J Allergy Clin Immunol 98, 205–215, 1996.
- Shahid NS, Steinhoff MC, Hoque SS, Begum T, Thompson C, et al.: Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 346, 1252–1257, 1995.
- O'Dempsey TJ, McArdle T, Ceesay SJ, Banya WA, Demba E, et al.: Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy. Vaccine 14, 963–970, 1996.
- Simonsen V, Brandao AP, Brandileone MC, Yara TI, Di Fabio JL, et al.: Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly. Braz J Med Biol Res 38, 251–260, 2005.
- French N, Moore M, Haikala R, Kayhty H, and Gilks CF. A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults. J Infect Dis 190, 707–712, 2004.
- Lesprit P, Pedrono G, Molina JM, Goujard C, Girard PM, et al.: Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults. AIDS 21, 2425–2434, 2007.
- Gills S, Blackstock W, and Goldberg RM: Colorectal cancer. Mayo Clin Proc 82, 114–129, 2007.
- Sinisalo M, Aittoniemi J, Oivanen P, Käyhty H, Olander RM, et al.: Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia. Br J Haematol 114, 107–110, 2001.
- Sinisalo M, Aittoniemi J, Oivanen P, Käyhty H, Olander RM, et al.: Haemophilus Influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukaemia: predicting factors for response. Leuk Lymphoma 43, 1967–1969, 2002.
- Tipu MK, Saleem U, Hussain K, Muhammad K, Hashmi FK, et al.: The role of zinc on anti-Newcastle disease virus specific antibody response and agranulocytes count in rabbits treated with methotrexate and prednisolone. Pak J Pharm Sci 25, 845–849, 2012.
- Gardner EM, BernsteinED, PopoffKA, AbrutynE, GrossP, et al.: Immune response to influenza vaccine in healthy elderly: lack of association with plasma beta-carotene, retinol, alpha-tocopherol, or zinc. Mech Ageing Dev 117, 29–45, 2015.
- Karlsen TH, Sommerfelt H, Klomstad S, Andersen PK, Strand TA, et al.: Intestinal and systemic immune responses to an oral cholera toxoid B subunit whole-cell vaccine administered during zinc supplementation. Infec Imun 2, 3909–3913, 2003.
- Qadri F, Ahmed T, Mohammad AW, Ahmed F, Bhuiyan NA, et al.: Supressive effect of zinc on antibody response to cholera toxine in children given the killed, B subunit-whole cell, oral cholera vaccine. Vaccine 22, 416–421, 2004.
- Albert MJ, Qadri F, Wahed MA, Ahmed T, Rahman AS, et al.: Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine. J Infect Dis187, 909–913, 2003.
- Ahmed T, Arifuzzaman M, Lebens M, Qadri F, and Lundgren A: CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation. Vaccine 28, 422–429, 2010.
- Overbeck S, Rink L, and Haase H: Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases. Arch Immunol Ther Exp (Warsz) 56, 15–30, 2008.
- Provincial M, Montenovo A, Di Stefano G, Colombo M, Daghetta L, et al.: Effect of zinc or zinc plus arginine supplementation on antibody titre and lymphocyte subsets after influenza vaccination in elderly subjects: a randomized controlled trial. Age Aging 27, 715–722, 1998.
- Park S and Nahm MH: Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations. Infect Immun 79, 314–320, 2011.
- Song JY, Moseley MA, Burton RL, and Nahm MH: Pneumococcal vaccine and opsonic pneumococcal antibody. J Infect Chemother 19, 412–425, 2013.